ReviewArchives of virology2025
Tahyna virus: an emerging threat to public health.
Review in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacological targeting of bunyavirus-induced synaptic impairment prevents neuronal hyperexcitability.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tahyna virus (TAHV), a member of the California serogroup of the genus Orthobunyavirus, is an arbovirus that is capable of causing a range of symptoms from mild febrile illnesses to severe neuroinvasive disease. It was first isolated in Europe and has a holarctic distribution, spanning Central Europe, Asia, and Africa. Central Europe has reported the highest reported human seropositivity rate, reaching 30%. Phylogenetic analysis has revealed a close relationship between TAHV and Lumbo virus (LUMV), with 94% amino acid sequence identity in their N proteins. TAHV is mainly transmitted by Aedes mosquitoes, and its vertebrate hosts include hares, rabbits, hedgehogs, and rodents. Flooding during the summer months due to climate change may be a catalyst for the spread of the virus. Despite the enormous potential threat of TAHV and its potential to cause meningitis, there is a notable dearth of information regarding its actual prevalence, the number of symptomatic cases, and its clinical manifestations in humans and animals. To date, no deaths have been attributed to TAHV, which might contribute to an underestimation of its public health significance. Given the anticipated future changes in climatic conditions, TAHV could pose a health threat in Europe and elsewhere. In this review, we summarize recent advancements in TAHV research, highlighting the need for enhanced research and resource allocation for its prevention and control.
Indexed as
Identifiers
39928175What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.